Dr Qinglu Cheng & Dr David Boettiger – Celebrating Health Economics and Health Systems Research at the Kirby Institute

Event date
Tuesday 5th October 2021
Event time
1:00 PM
Event address
Online event



Webinar via Zoom
Please click on the link just before the start of the webinar




Contact for enquiries 

Rata Joseph, +61 (2) 9385 0900 or info@kirby.unsw.edu.au


Kirby Institute Seminar Series presents

Dr Qinglu Cheng  

Dr Qinglu Cheng
Research Fellow, Surveillance and Evaluation Research Program, Kirby Institute

Qinglu Cheng is a Research Fellow at the Surveillance Evaluation & Research Program at the Kirby Institute. She holds a PhD in health economics. She currently works on projects that evaluate the cost-effectiveness of screening strategies for anal high-grade squamous intraepithelial lesions and screening hepatitis C infection in blood donations in Australia.

Dr David Boettiger  

Dr David Boettiger
Research Fellow, Biostatistics and Databases Program, Kirby Institute

David Boettiger is an epidemiologist and health economist at the Kirby Institute, with academic affiliations at the University of California San Francisco and Chulalongkorn University in Bangkok. He is an expert in the management of HIV and HIV-associated comorbidities, including cardiovascular disease and cancer. David collaborates extensively with international partners, including the WHO, World Bank, and US CDC, and his work has significantly enhanced global HIV policy.



The Kirby Institute's Cross Cutting Initiative in Health Economics and Health Systems is pleased to present its second seminar in the series celebrating the world class research being done at the Kirby Institute.

Equity of Health Financing in Indonesia: A 5-year Financing Incidence Analysis (2015–2019)
Dr Qinglu Cheng
In 2014, Indonesia launched a single payer national health insurance scheme, Jaminan Kesehatan Nasional (JKN), with the aim of covering the entire population by the end of 2024. In this study, a financing incidence analysis, also known as progressivity analysis, was conducted to measure how the burden of health financing across socioeconomic groups has changed over 2015–2019. In a progressive health system, the proportion of income contributed to financing health care increases with income. A regressive health system is socially unfair, as people with lower income contribute a higher proportion of their income. This study found that direct taxes and out-of-pocket payments were progressive sources of health financing in Indonesia, while indirect tax payments were all regressive for 2015–2019. Social health insurance was regressive except in 2017 and 2018. The overall health financing system was progressive from 2015 to 2018 but became regressive in 2019. The declining progressivity of the overall health financing system in 2015–2019 suggests that Indonesia still has a way to go in developing a fair and equitable health financing system to ensure that the poor are financially protected.

Cost-effectiveness of pre-anal cancer screening in gay and bisexual men living with HIV
Dr David Boettiger
Anal cancer occurs more frequently in gay and bisexual men (GBM) living with HIV than in the general population (incidence of 82–89 versus 1–2 per 100,000 person-years). Early detection and treatment of pre-cancerous lesions in HIV-positive GBM may be a cost-effective method of closing this gap. This seminar will describe early findings from a model parameterised with recent data from the Kirby-led SPANC study and built to assess the cost-effectiveness of pre-anal cancer screening among HIV-positive GBM in Australia.

Opinions expressed in the Kirby Institute Seminar Series are solely those of the speaker and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.